- Home
- NUWE vs CNSP Comparison
NUWE vs CNSP Comparison
Compare NUWE & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- CNSP
- Stock Information
- Founded
- NUWE 1999
- CNSP 2017
- Country
- NUWE United States
- CNSP United States
- Employees
- NUWE N/A
- CNSP N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- CNSP Health Care
- Exchange
- NUWE Nasdaq
- CNSP Nasdaq
- Market Cap
- NUWE 5.2M
- CNSP 5.6M
- IPO Year
- NUWE N/A
- CNSP 2019
- Fundamental
- Price
- NUWE $0.94
- CNSP $1.28
- Analyst Decision
- NUWE Strong Buy
- CNSP Hold
- Analyst Count
- NUWE 1
- CNSP 1
- Target Price
- NUWE $17.00
- CNSP N/A
- AVG Volume (30 Days)
- NUWE 81.7K
- CNSP 324.1K
- Earning Date
- NUWE 05-06-2025
- CNSP 05-14-2025
- Dividend Yield
- NUWE N/A
- CNSP N/A
- EPS Growth
- NUWE N/A
- CNSP N/A
- EPS
- NUWE N/A
- CNSP N/A
- Revenue
- NUWE $8,740,000.00
- CNSP N/A
- Revenue This Year
- NUWE $22.96
- CNSP N/A
- Revenue Next Year
- NUWE $29.97
- CNSP N/A
- P/E Ratio
- NUWE N/A
- CNSP N/A
- Revenue Growth
- NUWE N/A
- CNSP N/A
- 52 Week Low
- NUWE $0.90
- CNSP $1.21
- 52 Week High
- NUWE $14.35
- CNSP $965.00
- Technical
- Relative Strength Index (RSI)
- NUWE 30.44
- CNSP 31.86
- Support Level
- NUWE $0.91
- CNSP $1.28
- Resistance Level
- NUWE $1.03
- CNSP $3.82
- Average True Range (ATR)
- NUWE 0.07
- CNSP 0.38
- MACD
- NUWE -0.02
- CNSP -0.13
- Stochastic Oscillator
- NUWE 16.13
- CNSP 5.60
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.